BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15848908)

  • 1. Quality of treatment in routine care in a population sample of rectal cancer patients.
    Engel J; Kerr J; Eckel R; Günther B; Heiss M; Heitland W; Jauch KW; Siewert JR; Hölzel D
    Acta Oncol; 2005; 44(1):65-74. PubMed ID: 15848908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients.
    Engel J; Kerr J; Eckel R; Günther B; Heiss M; Heitland W; Siewert JR; Jauch KW; Hölzel D
    Eur J Surg Oncol; 2005 Jun; 31(5):512-20. PubMed ID: 15878259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
    Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
    Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany).
    Wulf J; Krämer K; van Aaken C; Dietzel F; Lucas D; Pfändner K; Schimpke T; Schulze W; Thiel HJ; Ziegler K; Flentje M
    Strahlenther Onkol; 2004 Jan; 180(1):5-14. PubMed ID: 14704839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
    Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
    Fietkau R; Zettl H; Klöcking S; Kundt G
    Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.
    Hölscher G; Anthuber C; Bastert G; Burges A; Mayr D; Oberlechner E; Schubert-Fritschle G; Sinz S; Sommer H; Schmalfeldt B; Engel J;
    Acta Obstet Gynecol Scand; 2009; 88(4):440-8. PubMed ID: 19191075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current management of rectal cancer.
    Ross HM; Mahmoud N; Fry RD
    Curr Probl Surg; 2005 Feb; 42(2):72-131. PubMed ID: 15735619
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
    Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
    Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined-modality therapy with sphincter-preserving total mesorectal excision for locally advanced rectal cancer: patient's age and long-term outcome.
    Szynglarewicz B; Matkowski R; Maciejczyk A; Kasprzak P; Forgacz J; Pudelko M
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):49-52. PubMed ID: 18392244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
    Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
    J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide quality assurance of rectal cancer treatment.
    Wibe A; Carlsen E; Dahl O; Tveit KM; Weedon-Fekjaer H; Hestvik UE; Wiig JN;
    Colorectal Dis; 2006 Mar; 8(3):224-9. PubMed ID: 16466564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical prognostic factors in malignant parotid gland tumors.
    Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.